Opaleye Management Inc. Arvinas, Inc. Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
A detailed history of Opaleye Management Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 555,000 shares of ARVN stock, worth $13.5 Million. This represents 3.78% of its overall portfolio holdings.
Number of Shares
555,000
Previous 330,000
68.18%
Holding current value
$13.5 Million
Previous $13.6 Million
8.46%
% of portfolio
3.78%
Previous 3.31%
Shares
5 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
68.7MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$164 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$163 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$153 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$97.3 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$72.9 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.3B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...